The subgroup analysis showed that LGR5 expression was significantly associated with an unfavorable prognosis in patients with CRC when studies set the cutoff score at >6 (HR: 2.09, 95% CI: 1.36–3.21), suggesting that a higher cutoff score was more likely to lead to a differential conclusion. The gene discussed is LGR5; the disease is colorectal carcinoma.